Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-30

Clinical Trial Update: Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an anthrax vaccine (BioThrax) in combination with antibiotics has completed, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioThrax (Anthrax vaccine adsorbed)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Anthrax | Phase 2 | Status: COMPLETED | Results posted: 2021-06-30